These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27045)

  • 61. Selection for anticoagulant therapy in cardiac infarction using the heparin retarded coagulation time.
    PEEL AA
    Br Heart J; 1956 Jul; 18(3):378-84. PubMed ID: 13342301
    [No Abstract]   [Full Text] [Related]  

  • 62. Platelet surface activation and aggregation in myocardial infarction--electron microscopic observations.
    Schatz IJ; Riddle JM
    Adv Cardiol; 1970; 4():143-60. PubMed ID: 5493444
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effect of neocompensan (haemodesum) on the course of experimental myocardial infarct with arrhythmias in rabbits].
    Marshutina NV
    Farmakol Toksikol; 1978; 41(5):568-75. PubMed ID: 700080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Role of the thrombocytes in the pathogenesis of atherosclerosis].
    Gromnatskiĭ NI
    Kardiologiia; 1974 Nov; 14(11):62-6. PubMed ID: 4372444
    [No Abstract]   [Full Text] [Related]  

  • 65. [Role of age-related changes in the pathogenesis of myocardial infarct].
    Chebotarev DF; Korkushko OV; Chernetskaia LA
    Kardiologiia; 1974 Apr; 14(4):5-11. PubMed ID: 4836791
    [No Abstract]   [Full Text] [Related]  

  • 66. [Blood coagulation state in cerebral infarct and the results of using sodium citrate in the treatment complex].
    Kesler VM
    Zdravookhr Kirg; 1978; (1):35-9. PubMed ID: 24936
    [No Abstract]   [Full Text] [Related]  

  • 67. [Autoimmune reactions and blood coagulation status in patients with myocardial infarct].
    Dement'eva MP
    Kardiologiia; 1974 Jun; 14(6):113-4. PubMed ID: 4140947
    [No Abstract]   [Full Text] [Related]  

  • 68. [The effect of Tavan (SP-54) on the coagulation mechanism and fibrinolysis in patients receiving anticoagulant therapy].
    Kleynhans P; Retief FP; Bosman AR
    S Afr Med J; 1969 Dec; 43(49):1504-7. PubMed ID: 4188315
    [No Abstract]   [Full Text] [Related]  

  • 69. PHYSIOLOGY AND PATHOLOGY OF BLOOD COAGULATION. A REVIEW OF THE LITERATURE OF 1963. I.
    KOLLER F; LAEUBLI B; VOGEL-MENG J
    Thromb Diath Haemorrh; 1964 Jan; 10():502-74. PubMed ID: 14113386
    [No Abstract]   [Full Text] [Related]  

  • 70. Fibrinolysis after acute myocardial infarction and after the administration of oral anticoagulation drugs and intravenous heparin.
    LACKNER H; MERSKEY C
    S Afr Med J; 1959 Nov; 33():936. PubMed ID: 14413315
    [No Abstract]   [Full Text] [Related]  

  • 71. [On the evaluation of the effect of narcotic remedies on the thrombogenic characteristics of the blood in patients with acute myocardial infarction].
    Iosava KV
    Kardiologiia; 1967 Jul; 7(7):25-9. PubMed ID: 5607164
    [No Abstract]   [Full Text] [Related]  

  • 72. [Results of the heparin treatment of children with hemorrhagic vasculitis].
    Panchenko MD; Ryneĭskaia VA; Kozarezova TI; Gurevich OE; Artemenko AG
    Pediatriia; 1979 Aug; (8):22-6. PubMed ID: 481995
    [No Abstract]   [Full Text] [Related]  

  • 73. [The treatment of myocardial infarct with polarizing and fibrinolysin-polarizing mixtures].
    Ianushkevichus ZI; Bluzhas IN; Vitkus AS
    Kardiologiia; 1966; 6(4):48-53. PubMed ID: 4234677
    [No Abstract]   [Full Text] [Related]  

  • 74. [Functional changes in thrombocytes and erythrocytes in myocardial infarct].
    Tunian IuS; Akopov SE; Melikian NG; Melkumova AG
    Kardiologiia; 1983 Jan; 23(1):99-100. PubMed ID: 6834690
    [No Abstract]   [Full Text] [Related]  

  • 75. [Changes in the coagulation activity of the blood during reversible myocardial infarct].
    Orlova NP; El'gort PE
    Kardiologiia; 1967 Oct; 7(10):26-8. PubMed ID: 5607195
    [No Abstract]   [Full Text] [Related]  

  • 76. Alterations of fibrinolysis and blood coagulation.
    Sharnoff JG
    Lancet; 1969 Feb; 1(7588):259-60. PubMed ID: 4178617
    [No Abstract]   [Full Text] [Related]  

  • 77. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 78. [Coagulation of arterial and venous blood in acute myocardial infarct].
    Ternovoĭ KS; Butylin IuP; Rozhnov IuV
    Kardiologiia; 1976 Oct; 16(10):119-23. PubMed ID: 1018415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Physiochemical properties of blood in postmyocardial infarction patients and controls.
    Groover ME; Stout C
    Angiology; 1966 Feb; 17(2):85-95. PubMed ID: 5904307
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effect of heparin, obsidan and rheogluman on lymph coagulating activity and flow rate in acute myocardial infarction].
    Ismailova ZD; Mamedov IaD; Mirzabekova FI; Garaev GSh
    Patol Fiziol Eksp Ter; 1991; (5):22-4. PubMed ID: 1725457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.